Back to Blog
Editorial lifestyle photograph illustrating a 2026 GLP-1 cost guide
AnalysisCost & InsuranceJULY 6, 2026· 11 min read
By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

Compare GLP-1 medication costs, insurance options, manufacturer savings and provider fees. Understand the difference between a medication price and the full cost of a program, then explore the providers in our approved partner comparison.

Independently researched. Every statistic links to a primary source (NEJM, JAMA, FDA, CMS, or the provider's official disclosures). Affiliate status never changes a provider's score; featured picks are affiliate partners, disclosed. Last verified September 20, 2026.

Summarize this article with

In this article
  1. 01How Much Do GLP-1 Medications Cost Without Insurance?
  2. 02How Do GLP-1 Savings Cards Work?
  3. 03Does Medicare Cover GLP-1 Medications?
  4. 04Does Insurance Cover GLP-1 Medications for Weight Loss?
  5. 05How Much Do Telehealth GLP-1 Programs Cost?
  6. 06Can You Use FSA or HSA for GLP-1 Medications?
  7. 07Does Medicaid Cover GLP-1 Medications?

Verified July 2026: GLP-1 medications, Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo, cost between $25 and $1,350 per month in the July price snapshot. With a manufacturer savings card + commercial insurance, eligible patients may pay $25/month for some brands, subject to program terms. Without insurance: Embody advertises compounded semaglutide from $79 on a selected plan, Enhance MD advertises $212/mo on the 12-month plan ($249/mo month-to-month) for compounded semaglutide or $99 first month ($280/mo after) for compounded tirzepatide, Foundayo starts at $149/mo at the 0.8 mg strength via LillyDirect, and Sprout Health starts at $199 first month ($249/mo after) for telehealth with both brand and compounded options plus a dedicated care coordinator. At a September 20 price check, Foundayo is $149 at 2.5 mg (promotion through December 31, 2026; regular $199) and $199 at 5.5 mg (promotion through December 31, 2026; regular $299) or $299 at 9 mg; 14.5 mg and 17.2 mg remain $299 only when refilled within 45 days, otherwise $349. The manufacturer-direct snapshot was re-checked in August: NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and pill from $149/month, prescription required and dose-dependent; LillyDirect listed Zepbound from $299/month, with higher-dose pricing under its stated refill terms. Medicare Part D beneficiaries get $50/month via the GLP-1 Bridge program live as of July 1, 2026.

Quick answer by scenario: Have commercial insurance that covers Wegovy/Zepbound/Foundayo → apply the savings card, pay $25/mo if eligible and within the offer terms. Uninsured and want a low advertised cash-pay entry → Embody (semaglutide from $79 on a selected plan) or Enhance MD (semaglutide $212/mo on a 12-month plan, $249 month-to-month). Uninsured and want a brand-name pill → Foundayo at $149/mo (lowest dose) via LillyDirect. Uninsured and want brand-name injectable → LillyDirect ($299/mo Zepbound) or NovoCare Wegovy ($199/mo for the first two low-dose fills, then $349/mo at standard strengths or $399 HD). Uninsured and want comprehensive clinical oversight → Sprout Health $199 first month, then $249/mo includes a dedicated care coordinator, published 12-15% body weight loss outcomes at 6 months, and an established 2022+ operating track record. Medicare beneficiary → the GLP-1 Bridge program may cover eligible weight-management use at $50/mo. Use our cost calculator to estimate your monthly spend, see all providers sorted by lowest price, or take the 60-second match quiz.

This guide breaks down every pricing option: brand-name list prices, manufacturer direct-to-consumer programs (LillyDirect, NovoCare), the new Foundayo oral pill (see all oral GLP-1 pills compared), compounded telehealth providers, savings cards, Medicare/Medicaid coverage, and how the savings structures actually work. All prices verified July 2026 against provider websites and manufacturer announcements. Sources: CMS GLP-1 Bridge Demonstration, Zepbound savings card terms, Wegovy savings offer, Foundayo savings card.

Comparing your options?

Compare GLP-1 programs by medication, care and total payment commitment. Check upfront charges and separate membership fees alongside advertised monthly prices.

Compare all 36 GLP-1 providers →

How Much Do GLP-1 Medications Cost Without Insurance?

List prices (what pharmacies charge before discounts) don't reflect what most people pay. Here's the full picture:

MedicationList PriceSelf-Pay/DirectWith Insurance + Savings Card
Wegovy (injection)~$1,349/mo$199/mo first two low-dose fills; then $349 standard / $399 HD (NovoCare)As low as $25/mo, if eligible
Wegovy (oral pill)~$1,349/moFrom $149/mo (NovoCare, dose-dependent)As low as $25/mo
Ozempic$1,027.51/mo$199/mo first two low-dose fills; then $349 at 0.25-1mg / $499 at 2mg (NovoCare)As low as $25/mo, if eligible
Zepbound~$1,086/mo$299 to 449/mo (LillyDirect KwikPens/vials)As low as $25/mo
Mounjaro$1,112.16/moNo manufacturer cash program verifiedAs low as $25/mo, if eligible
Foundayo (orforglipron)~$649/mo$149-349/mo (LillyDirect; dose and 45-day refill terms apply)As low as $25/mo
Saxenda (brand)~$1,349/mo~$372/mo (GoodRx coupon)As low as $25/mo
Generic liraglutide (Teva)~$1,165/moCheck GoodRxVaries
Coming 2027:Novo Nordisk announced that effective January 1, 2027, list prices for Wegovy, Ozempic, and Rybelsus will drop to approximately $675/month, a 50-70% reduction from current list prices. Saxenda is on a different track: Novo is discontinuing it, with last shipments to wholesalers in late January 2027, so budget for it only through that window. See our Saxenda discontinuation and switching guide for which liraglutide products remain available.
The GLP-1 Letter · Free

Join the list for the GLP-1 Letter.

We re-verify every price on this site against the provider's own live page and check every program against the FDA warning letter database. Join the list and you will hear from us when that work turns up something worth an email. No promised schedule until we are actually keeping one. Unsubscribe anytime.

No affiliate spam. No retargeting pixels. Unsubscribe in one click.

How Do GLP-1 Savings Cards Work?

Both major manufacturers offer significant savings cards. These are the most impactful way to reduce your cost if you have commercial insurance:

Novo Nordisk (Wegovy, Ozempic, Saxenda): If you have commercial insurance that covers your medication, savings cards can bring your copay down to $25 per fill, subject to eligibility and program terms. For cash-pay patients, NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and oral pill from $149/month when checked August 7, 2026; a prescription is required and pricing is dose-dependent. Novo's March 31 launch included separate multi-month Wegovy offers at $249 to $329/month for the injection and $249 to $289/month for the pill through participating partners. Those dated launch terms should not be substituted for the current manufacturer-direct floor. Text SAVE to 83757 for a digital savings card.

Eli Lilly (Zepbound, Mounjaro, Foundayo): Eligible commercially insured patients may qualify for copays as low as $25 per fill under each program's terms. If insurance does not cover Zepbound, its savings-card price may be $499/month. LillyDirect lists self-pay Zepbound from $299 to $449/month depending on dose and refill terms. For Foundayo, LillyDirect lists $149/month at 0.8 mg, $149 at 2.5 mg (promotion through December 31, 2026; regular $199), $199 at 5.5 mg (promotion through December 31, 2026; regular $299) or $299 at 9 mg, and $299 at 14.5 mg or 17.2 mg only when refilled within 45 days, otherwise $349. Check the current Foundayo savings-card terms and the medication-specific expiration and eligibility rules before relying on a copay figure.

Important:None of the manufacturer savings programs work for Medicare, Medicaid, or other government insurance beneficiaries. If you're on Medicare, the GLP-1 Bridge program (live as of July 2026) is your best option.

Does Medicare Cover GLP-1 Medications?

This is the biggest cost development of 2026. CMS launched the Medicare GLP-1 Bridge Demonstration on July 1, 2026:

  • Beneficiary copay: $50/month for GLP-1 medications
  • Negotiated manufacturer price: $245/month (paid by the program)
  • Covers Wegovy, Zepbound (KwikPen only), and Foundayo
  • Eligibility: Medicare Part D enrollees meeting BMI criteria and related health conditions
  • Estimated ~10% of Medicare beneficiaries expected to qualify

The longer-term BALANCE Model is set to launch in January 2027 for Medicare and May 2026 for state Medicaid agencies that opt in. This combines GLP-1 access with lifestyle supports and allows CMS to negotiate drug pricing on behalf of participating plans.

Editor's Top Pick

Embody

from $69/mo · 7.3/10 · Compounded

Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan.

Does Insurance Cover GLP-1 Medications for Weight Loss?

Insurance coverage for GLP-1s is actually getting more restrictive for weight loss in 2026, despite growing demand:

  • 8.5% of commercially insured people (16+ million) have no GLP-1 coverage for weight loss at all
  • The number of people without Wegovy coverage specifically increased 42% vs 2025, over 41 million without access
  • Major insurers including BCBS, Cigna, and UnitedHealthcare implemented new restrictions as of January 2026, mostly limiting coverage to Type 2 diabetes only
  • Most insurers still cover Ozempic/Mounjaro for diabetes, restrictions primarily hit weight-loss-only indications
Verify Your Provider Match

Not sure which GLP-1 program is right for you?

Take the 60-second quiz, we'll compare approved partners on your goals, budget, and medication preference, then surface your top 3.

Take the 60-sec Quiz

How Much Do Telehealth GLP-1 Programs Cost?

Online telehealth providers often offer lower total costs by bundling consultation fees with medication, though what the bundle covers varies more than the headline suggests. Confirm whether the quote includes the consultation, medication, shipping and any required membership. Here's a sample of what platforms charge:

PlatformMonthly CostWhat's Included
Strut Health$149/moOral compounded semaglutide; FDA warning #721448 concerns marketing claims
Enhance MD$49 to $99 first mo, then $212 to $280/moCompounded semaglutide or tirzepatide, combo therapy options
TrimRx$179 advertised floor; total under reviewTerms list semaglutide at $199/$299 and GLP-1 + GIP at $349/$399; 5.3/10 after verified fulfillment-pattern modifier
Found$264/moBrand or compounded options, behavior coaching, insurance accepted
Ro$344/moBrand Wegovy via Novo subscription, metabolic labs, clinical support
LillyDirect$299 to $449/moZepbound brand KwikPens/vials, direct from manufacturer
NovoCare PharmacyWegovy pen at $199/mo for the first two low-dose fills, then $349/mo at standard strengths ($399 for HD); pill from $149/moBrand medication direct from Novo Nordisk; prescription required, dose-dependent

Advertised sale pricing is where these comparisons go wrong most often. bmiMD is the clearest case in our data: its $119/mo semaglutide and $179/mo tirzepatide rates both require a 12-month plan, while the month-to-month entry rate is $289. Before you compare a promotional quote against anything in the table above, check which of those two it is. The second pattern to watch is the promotional price with no deadline attached: SnagRx advertises $69/mo compounded semaglutide beside a countdown that is a standing feature of the page rather than a dated expiry, and its own terms refer to non-refundable medical consult fees its homepage does not mention, so read that as a medication floor and not a checkout total.

We rank 34 telehealth GLP-1 providers by price, see the full list sorted cheapest-first, or take the 60-second match quiz to find the best provider for your insurance, budget, and medication preference. For tirzepatide specifically, see our cheapest tirzepatide page. If you are pricing one platform in particular, our review breaks down how much Willow's GLP-1 program costs tier by tier, alongside its Trustpilot and BBB records. The cheapest advertised rate is only worth taking if the company behind it checks out, which is why we publish the underlying verification separately: the Trimi reviews and legitimacy check lays out what we could and could not confirm about the company behind one of the lowest annual-prepay rates we track.

A provider that does not publish a complete price cannot be compared as if its headline fee covers everything. Ask for the medication, program and shipping total before starting a paid intake.

Can You Use FSA or HSA for GLP-1 Medications?

GLP-1 medications are FSA and HSA eligible when prescribed for a documented medical condition (obesity, Type 2 diabetes, metabolic syndrome). This applies to all brand-name GLP-1s, compounded versions with a valid prescription, and in many cases the telehealth consultation fees as well. You'll need a valid prescription and medical documentation, purely cosmetic weight loss without a medical diagnosis may not qualify.

Does Medicaid Cover GLP-1 Medications?

As of January 2026, only 13 state Medicaid fee-for-service programs cover GLP-1s for obesity treatment, down from 16. California, New Hampshire, Pennsylvania, and South Carolina recently eliminated coverage. Michigan added strict requirements including morbid obesity classification and documented failure of other interventions.

The BALANCE Model allows state Medicaid agencies to opt in starting May 2026, with CMS negotiating drug pricing on their behalf. This could expand access, but it's voluntary.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.

Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.

Featured GLP-1 option: Embody

from $69/mo. Check the plan conditions, or run the numbers across 36 providers first.

Featured affiliate pick, we may earn a commission · scores set by our methodology, not payment

Compare every GLP-1 program in one place

See all 36 verified providers ranked side by side on price, medication, and our independent score, or jump straight to the cheapest verified prices.

Medicare & GLP-1

Medicare GLP-1 Coverage Guide

Saw Medicare mentioned in "GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)"? Here's exactly what's covered, who qualifies, and how the $50/mo Bridge copay works from July 1, 2026.

Read the Medicare Coverage Guide →
Independent Clinical Perspective

What the doctors say

Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.

Americans should be confident that the prescription drugs they take are safe. By strengthening oversight of imported APIs and cracking down on illegal drugs entering the U.S., we are taking aggressive action to protect consumers from poor-quality or dangerous GLP-1 drugs.
Marty Makary, MD, MPH, FDA Commissioner
U.S. Food and Drug Administration
Announcing the FDA 'Green List' to block illegally imported GLP-1 active ingredients used in compounding.
While compounding can play an appropriate role when used to meet the specific needs of an individual patient, the large-scale production and marketing of compounded versions of these medicines raises serious safety risks when products have not undergone the rigorous scientific and regulatory review required for FDA-approved therapies.
Jacqueline M. Stephens, PhD, FTOS, President, The Obesity Society
The Obesity Society
Official Obesity Society statement on compounded GLP-1 medications.
It's not just filling out a form online and then having some random healthcare provider sign off on it. There are concerns with some of these online programs that there's not a proper evaluation, there's not a baseline, and there's not proper supervision.
Marc-Andre Cornier, MD, endocrinologist; immediate past president of The Obesity Society
Medical University of South Carolina
On why some online/telehealth GLP-1 programs fall short of a proper clinical standard of care.

Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Embody

7.3/10
from $69/mo·Compounded

Gala

7.2/10
from $149/mo·Brand & Compounded

Ro

7.2/10
$149/mo membership + medication·Brand

Fridays

8.7/10
from $117/mo·Brand & Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at GLP-1 Picks comparison.